Fund Tracker India by Ishaan Dungarwal
Guide

Invesco India Pharma and Healthcare Fund

Holdings for Oct 2026, changes against Sep 2026, from Invesco Mutual Fund's monthly file.

Invesco India Pharma and Healthcare Fund portfolio holdings, Oct 2026: 15 stocks, ₹462 cr in listed equity, from Invesco Mutual Fund's monthly disclosure; changes by share count against Sep 2026.

Fund managers: Aditya Khemani

Benchmark: BSE Healthcare TRI · Riskometer: Very High · SEBI category, as filed: Sectoral Fund ·

Source: AMFI scheme summary document

NAV

Invesco India Pharma and Healthcare Fund - Direct Plan - Growth

Source: AMFI

₹10.780020 Nov 2026
AUM

average for July - September 2026, all plans.

Source: AMFI

₹111 crJuly - September 2026
Expense ratio

The scheme's yearly running cost as a % of its assets, taken out of the NAV a little each day. A regular plan costs more: it pays a distributor's commission.

Category median: direct 1.06 %, regular 2.50 % (20 schemes) · Regular costs ₹1,890 more a year per ₹1 lakh

Of this, the base expense ratio, the part SEBI caps: direct 0.48 %, regular 2.08 %. The rest is brokerage, transaction costs and statutory levies such as GST and STT, as AMFI's file lists them.

A year, as of 21 Nov 2026. Source: AMFI · Glossary: TER

Direct 1.90 %Regular 3.79 %
Equity held

15 stocks, Oct 2026.

Source: Invesco Mutual Fund monthly portfolio

₹462 cr15 stocks · Oct 2026
Equity, % of fund

As the AMC's file prints % of NAV. The top 10 stocks together: 78.1%.

97.0%top 10 stocks 78.1%

This month: Oct 2026

compared with Sep 2026 · by share count

Equity held vs NAV

The teal line is the scheme's equity at month end, from its portfolio file; the faint line is the plan's NAV. Equity held moves with prices and with money in or out, the NAV with prices only.

last 2 months to Oct 2026
Sep 2026: equity held ₹379 cr, 13 stocks, NAV ₹9.59Oct 2026: equity held ₹462 cr, 15 stocks, NAV ₹9.66
% change and month by month (tables)
% change to Oct 2026
OverSinceEquity heldNAV
3 monthsbefore Sep 2026——
6 monthsbefore Sep 2026——
12 monthsbefore Sep 2026——
MonthEquity heldStocksNAV at month end
Sep 2026₹379 cr13₹9.5900
Oct 2026₹462 cr15₹9.6600
Oct 2026 · Sources: AMC monthly portfolio (SEBI disclosure); AMFI NAV files · How to read

Moves, Oct 2026

How many stocks the scheme bought into, added to, cut or sold out of this month, by share count, so a price move alone never counts.

vs Sep 2026
  • New2
  • Added11
  • Trimmed0
  • Exited0
Stocks, by share count · Source: Invesco Mutual Fund monthly portfolios Report a wrong number

Asset mix, Oct 2026

How much of the fund sits in listed shares; the rest is foreign shares, debt, money market, cash and other assets.

% of fund
  1. Listed equity
    97.0%
  2. Rest, not itemised
    3.0%
Source: Invesco Mutual Fund monthly portfolio

Rest = foreign shares, debt, money market, cash, REIT/InvIT units and other assets.

Sectors and top 10, Oct 2026

Sector mix, Oct 2026

How the scheme's equity is spread across sectors at month end.

% of equity held
  1. 100.0%
Source: Invesco Mutual Fund monthly portfolio; AMFI

AMFI's 22 sectors; one sector per stock, from the fund houses' industry labels.

Report a wrong number

Large, mid and small cap, Oct 2026

How the scheme's equity splits across large, mid and small companies, on AMFI's list.

% of equity held
  1. Small Cap
    33.5%
  2. Large Cap
    31.5%
  3. Mid Cap
    19.3%
  4. Not in AMFI's list
    15.7%
Source: Invesco Mutual Fund monthly portfolio; AMFI

AMFI's list of Jun 2026.

Report a wrong number

Top 10 holdings

Its ten largest stocks, each as a share of the fund.

% of fund · 78.1% together
Source: Invesco Mutual Fund monthly portfolio

As the AMC's file prints % of NAV.

Changes, Oct 2026 vs Sep 2026

Every stock whose share count changed: new, added, trimmed, exited.

13 stocks · by share count
StockChangeShares beforeShares nowDifferenceChange %Value of changeValue now
SMT New—7.52 lakh+7.52 lakh—+₹34.8 cr₹34.8 cr
MANKIND New—38,784+38,784—+₹9.7 cr₹9.7 cr
APOLLOHOSP Added42,81851,154+8,336+19.5%+₹7.0 cr₹43.2 cr
DIVISLAB Added36,77742,503+5,726+15.6%+₹5.6 cr₹41.6 cr
MAXHEALTH Added4.49 lakh4.76 lakh+26,817+6.0%+₹2.3 cr₹40.9 cr
SAILIFE Added2.46 lakh2.59 lakh+12,972+5.3%+₹2.0 cr₹40.4 cr
SUNPHARMA Added2.16 lakh2.22 lakh+6,845+3.2%+₹1.2 cr₹39.5 cr
MANIPALHOS Added4.90 lakh5.67 lakh+76,489+15.6%+₹5.1 cr₹37.9 cr
AGARWALEYE Added5.75 lakh7.41 lakh+1.66 lakh+29.0%+₹8.5 cr₹37.7 cr
GLENMARK Added90,71692,796+2,080+2.3%+₹0.48 cr₹21.3 cr
TORNTPHARM Added44,68945,588+899+2.0%+₹0.41 cr₹21.0 cr
KIMS Added2.76 lakh2.97 lakh+21,184+7.7%+₹1.5 cr₹20.8 cr
ASTERDM Added1.24 lakh2.51 lakh+1.27 lakh+101.8%+₹8.6 cr₹17.1 cr
Source: Invesco Mutual Fund monthly portfolios

Value of change = the difference in shares × this month's price in the AMC's file. Value now = the whole holding's market value in that file (an exit: last month's).

How to read

Report a wrong number

Full portfolio, Oct 2026 (15 stocks)

Every listed stock in the month's file, largest first.

largest first, by value

Equity rows as disclosed, Oct 2026. Source: Invesco Mutual Fund monthly portfolio. Report a wrong number

Large, mid and small caps, % of net assets, last 12 months

AMFI list in force each month
MonthLargeMidSmallNot in AMFI's listAMFI list
Oct 202630.6%18.7%32.5%15.3%Jun 2026
Sep 202629.8%16.4%32.8%8.0%Jun 2026
Sources: Invesco Mutual Fund monthly portfolios; AMFI. How to read

Equity holdings' % of net assets each month, by AMFI's cap list in force that month.

Portfolio turnover, from holdings

equity only · month-end snapshots
Turnover, 1 month0.0%Sep 2026 to Oct 2026 · bought ₹87.2 cr, sold ₹0.00 cr
MonthBoughtSoldTurnover
Oct 2026₹87.2 cr₹0.00 cr0.0%
Sep 2026———
Source: Invesco Mutual Fund monthly portfolios. How to read

The lower of bought and sold over the average equity value, from month-end holdings; it can differ from the fund house's own figure.

Returns, Invesco India Pharma and Healthcare Fund - Direct Plan - Growth

What the plan's NAV did over each period, as AMFI publishes it.

NAV to NAV · Source: AMFI
PeriodReturnFromTo
Since first NAV+7.58 % in total 10 Sep 2026 · NAV ₹10.020020 Nov 2026 · NAV ₹10.7800

Past performance may not be sustained in future.

Source: AMFI NAV files

Change in the plan's NAV between the two dates shown, as AMFI publishes the NAVs (plan code 154547).

How to read

Report a wrong number

Not enough NAV history stored yet for rolling returns, calendar-year returns and a monthly SIP.

IDCW (dividend) history

0 declarations · as of 4 Nov 2026 · Source: AMFI
AMFI lists no IDCW declared by this scheme.
Source: AMFI scheme dividends. How to read

IDCW (formerly "dividend") declared per unit of each IDCW plan, as AMFI lists it.

Embed this card

Card for this scheme: facts with source and date

Copy this into any web page. The image carries its source, date and a link back; it is redrawn each night.

Portfolios most like this one, Oct 2026

same category, other fund houses
Most alike and most unique funds →

Overlap is the sum, over stocks both hold, of the smaller of the two weights. A measured likeness, not a suggestion to switch.

From AMFI's own files (scheme summary documents, NAV history, TER), as they stood on the day shown.

Questions about Invesco India Pharma and Healthcare Fund

from the figures on this page

What are the top holdings of Invesco India Pharma and Healthcare Fund?

At Oct 2026 end, Invesco India Pharma and Healthcare Fund held 15 stocks (97.0% of the fund in equity). Largest: Apollo Hospitals Enterprise 9.08%, Divi's Laboratories 8.74%, Max Healthcare Institute 8.59%, Sai Life Sciences 8.49%, Sun Pharmaceutical Industries 8.31%; the top 10 make up 78.1%. Funds holding Apollo Hospitals Enterprise · Funds holding Divi's Laboratories · Funds holding Max Healthcare Institute

What portfolio changes did Invesco India Pharma and Healthcare Fund make in Oct 2026?

Compared with Sep 2026, by share count: 2 new, 11 added, 0 trimmed, 0 exited. Largest by value: Sahajanand Medical Technologies (new), Mankind Pharma (new), Apollo Hospitals Enterprise (added), Divi's Laboratories (added).

Who manages Invesco India Pharma and Healthcare Fund?

AMFI's scheme summary document names Aditya Khemani for Invesco India Pharma and Healthcare Fund (Invesco Mutual Fund). Aditya Khemani, fund manager portfolio

All schemes of Invesco Mutual Fund →

Mutual fund investments are subject to market risks; read all scheme related documents carefully.